Literature DB >> 21225931

B-acute lymphoblastic leukemia and cystinuria in a patient with duplication 22q11.21 detected by chromosomal microarray analysis.

Vivian Y Chang1, Fabiola Quintero-Rivera, Erin E Baldwin, Kathy Woo, Julian A Martinez-Agosto, Cecilia Fu, Brigitte N Gomperts.   

Abstract

Duplication 22q11.2 syndrome is the result of a microduplication of the same chromosomal region that is deleted in DiGeorge and Velocardiofacial syndromes. We describe a patient with dysmorphic features who was diagnosed with pre-B acute lymphoblastic leukemia, and developed cystinuria and pancreatitis during treatment. Duplication 22q11.2 has not been previously described in association with hematologic abnormalities. Chromosomal microarray technology was used to diagnose duplication 22q11.2 syndrome. In this era of advanced genomics, this technology has become an important method for helping to determine the molecular basis of diseases, best treatments and ultimately patient outcomes.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21225931     DOI: 10.1002/pbc.22909

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  3 in total

1.  Dissecting the genotype in syndromic intellectual disability using whole exome sequencing in addition to genome-wide copy number analysis.

Authors:  Carl Friedrich Classen; Vera Riehmer; Christina Landwehr; Anne Kosfeld; Stefanie Heilmann; Caroline Scholz; Sarah Kabisch; Hartmut Engels; Sascha Tierling; Miroslav Zivicnjak; Frank Schacherer; Dieter Haffner; Ruthild G Weber
Journal:  Hum Genet       Date:  2013-04-04       Impact factor: 4.132

2.  Acute Pre-B Lymphoblastic Leukemia and Congenital Anomalies in a Child with a de Novo 22q11.1q11.22 Duplication.

Authors:  M Vaisvilas; V Dirse; B Aleksiuniene; I Tamuliene; L Cimbalistiene; A Utkus; J Rascon
Journal:  Balkan J Med Genet       Date:  2018-10-29       Impact factor: 0.519

3.  Significant evidence of linkage for a gene predisposing to colorectal cancer and multiple primary cancers on 22q11.

Authors:  Craig Teerlink; Quentin Nelson; Randall Burt; Lisa Cannon-Albright
Journal:  Clin Transl Gastroenterol       Date:  2014-02-27       Impact factor: 4.488

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.